Bilateral retrobulbar optic neuropathy as the only sign of zoledronic acid toxicity
In conclusion, patients treated with bisphosphonates should be informed about the possibility of ocular side-effects, and ophthalmologists should be consider discontinuing the drug.
Source: Journal of Clinical Neuroscience - Category: Neuroscience Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Neurology | Opthalmology | Prostate Cancer | Reclast | Toxicology | Zometa